Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Collaborations between academic and community cancer centers enhance access to care, with success in acute myeloid leukemia and precision oncology.

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...

The market for artificial sweeteners has been projected to increase by almost 75% from 2025 through 2033, or from $3.11 ...

A panelist discusses how a prospective study demonstrated that twice-daily use of a nasal spray significantly improved tear ...

A panelist discusses how personalized ITP care requires open conversations about testing costs, insurance coverage, and ...

The Braidwood decision maintains the status quo for many patients, keeping preventive services covered by Medicaid under the ...

Black men who were identified as sexual minorities were more receptive to long-acting injectable pre-exposure prophylaxis ...

Alexander I. Spira, MD, PhD, of The US Oncology Network, discusses findings from the COCOON trial that show prophylactic ...

Panelists discuss how healthcare resource utilization is primarily driven by hospitalizations, medication costs, and ...

Carrie Kitko, MD, explains that axatilimab maintains strong response rates in patients with chronic graft-versus-host disease (GVHD) regardless of previous treatment lines and emphasizes the need to ...